TR200102234T2 - Psödomonik asit A antibiyotiğinin mikrobiyolojik yöntem ile hazırlanması için işlem - Google Patents
Psödomonik asit A antibiyotiğinin mikrobiyolojik yöntem ile hazırlanması için işlemInfo
- Publication number
- TR200102234T2 TR200102234T2 TR2001/02234T TR200102234T TR200102234T2 TR 200102234 T2 TR200102234 T2 TR 200102234T2 TR 2001/02234 T TR2001/02234 T TR 2001/02234T TR 200102234 T TR200102234 T TR 200102234T TR 200102234 T2 TR200102234 T2 TR 200102234T2
- Authority
- TR
- Turkey
- Prior art keywords
- pseudomonic acid
- preparation
- antibiotic
- procedure
- pseudomonas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Fermentasyon yoluyla havalandirma kosullarinda esas olarak saf psödomonik asit A'nin biyosentezini yapabilen bir Pseudomonas bakteryum türünün daldirmayla yetistirilmesini ve istenen bilesigin izolasyonunu içeren, psödomonik asit A'nin hazirlanmasi için bir prosedür anlatilmistir. Özelde, bu bulusun prosedürü, organik azot ve karbon kaynaklarini ve istege göre mineral tuzlarini ihtiva eden, 23-30 C arasindaki sicaklikta bir ortam üzerinde, Ulusal Tarimsal ve Endüstriyel Mikroorganizmalar Koleksiyonu, Budapeste, Macaristan adresinde NCAIM (P)B 001235 erisim sayisi altinda biriktirilen No.19/26 Pseudomonas sp. bakteryum türünün ya da bu türün psödomonik asit A-üreten mutant ya da varyantinin yetistirilmesini içermektedir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11845799P | 1999-02-03 | 1999-02-03 | |
US13733499P | 1999-06-03 | 1999-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102234T2 true TR200102234T2 (tr) | 2002-10-21 |
Family
ID=26816383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02234T TR200102234T2 (tr) | 1999-02-03 | 2000-02-03 | Psödomonik asit A antibiyotiğinin mikrobiyolojik yöntem ile hazırlanması için işlem |
Country Status (22)
Country | Link |
---|---|
US (3) | US6509177B1 (tr) |
EP (1) | EP1151131A4 (tr) |
JP (1) | JP2003515311A (tr) |
KR (1) | KR20010113674A (tr) |
CN (2) | CN1203184C (tr) |
AU (1) | AU762768B2 (tr) |
BG (1) | BG105776A (tr) |
BR (1) | BR0009179A (tr) |
CA (1) | CA2360865A1 (tr) |
CZ (1) | CZ20012724A3 (tr) |
HK (1) | HK1041903A1 (tr) |
HR (1) | HRP20010576A2 (tr) |
HU (1) | HUP0300363A2 (tr) |
IL (2) | IL144679A0 (tr) |
IS (1) | IS6028A (tr) |
MX (1) | MXPA01007806A (tr) |
NO (1) | NO20013791L (tr) |
PL (1) | PL358615A1 (tr) |
SK (1) | SK10892001A3 (tr) |
TR (1) | TR200102234T2 (tr) |
WO (1) | WO2000046389A1 (tr) |
YU (1) | YU55601A (tr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000046389A1 (en) | 1999-02-03 | 2000-08-10 | Biogal Gyogyszergyar Rt | Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
AU2002345856A1 (en) | 2001-06-21 | 2003-01-08 | Biogal Gyogyszergyar Rt | Metabolic controlled fermentation process for pseudomonic acid production |
DE20220885U1 (de) * | 2001-12-28 | 2004-06-24 | BIOGAL Gyógyszergyár Rt. | Kristallines und amorphes Mupirocin-Calcium |
IL150907A (en) * | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
WO2005117837A1 (en) | 2004-06-01 | 2005-12-15 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Process for preparation of amorphous form of a drug |
US7619102B2 (en) | 2005-02-21 | 2009-11-17 | Axellia Pharmaceuticals Aps | Purification of mupirocin |
WO2009117310A2 (en) * | 2008-03-17 | 2009-09-24 | Cedars-Sinai Medical Center | Methods for treatment and prevention of mrsa/mssa |
CN104370896A (zh) * | 2013-11-29 | 2015-02-25 | 江苏汉邦科技有限公司 | 一种纯化假单孢菌素的方法 |
CN103820369B (zh) * | 2014-03-07 | 2015-11-18 | 浙江瑞邦药业有限公司 | 一种萤光假单胞菌及其应用 |
CN108277243B (zh) * | 2018-01-19 | 2021-03-12 | 浙江瑞邦药业股份有限公司 | 一种假单胞菌酸a的制备方法 |
CN108949845B (zh) * | 2018-08-08 | 2021-08-10 | 福建康鸿生物科技有限公司 | 一种发酵培养基及由发酵培养基制备莫匹罗星的方法 |
CN116867905A (zh) | 2021-02-07 | 2023-10-10 | 杭州中美华东制药有限公司 | 一种莫匹罗星的发酵方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1643240A1 (de) | 1966-09-16 | 1971-06-24 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane |
GB1395907A (en) | 1971-06-12 | 1975-05-29 | Beecham Group Ltd | Antibiotics |
US3977943A (en) | 1971-06-12 | 1976-08-31 | Beecham Group Limited | Antibiotics |
US4071536A (en) | 1971-06-12 | 1978-01-31 | Beecham Group Limited | Antibiotics |
JPS5270083A (en) * | 1975-12-04 | 1977-06-10 | Yoshitomi Pharmaceut Ind Ltd | Manufacture of an antibiotics, trans-pseudomonic acid |
GB1577730A (en) | 1976-10-23 | 1980-10-29 | Beecham Group Ltd | Treatment of infections with pseudomonicacid salts or esters thereof |
GB1577545A (en) | 1977-07-27 | 1980-10-22 | Beecham Group Ltd | Treatment of swine dysenter |
CA1103264A (en) | 1977-09-30 | 1981-06-16 | Norman H. Rogers | Purification of pseudomonic acid |
CA1115699A (en) | 1978-05-20 | 1982-01-05 | Alan D. Curzons | Lithium pseudomonate and its preparation |
CA1196284A (en) | 1982-05-28 | 1985-11-05 | Joshua Oduro-Yeboah | Pharmaceutical formulations |
GB8415579D0 (en) | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
GB8428952D0 (en) | 1984-11-16 | 1984-12-27 | Beecham Group Plc | Formulations |
GB8530796D0 (en) | 1985-12-13 | 1986-01-22 | Beecham Group Plc | Pharmaceutical composition |
IE59628B1 (en) | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
IN171883B (tr) | 1990-07-27 | 1993-01-30 | Hoechst India | |
US5594026A (en) | 1990-12-11 | 1997-01-14 | Smithkline Beecham Group P.L.C. | Polymorphs of crystalline mupirocin |
US5292892A (en) | 1991-05-07 | 1994-03-08 | Sankyo Company, Limited | Anti-bacterial compound and pharmaceutical compositions thereof |
US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
CN1239427A (zh) | 1996-10-01 | 1999-12-22 | 史密丝克莱恩比彻姆公司 | Mupirocin在制备用于治疗与病原生物体鼻咽建群有关的细菌感染的药物中的应用 |
US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
HUP0105286A3 (en) | 1999-02-03 | 2003-03-28 | Biogal Gyogyszergyar | Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth |
WO2000046389A1 (en) | 1999-02-03 | 2000-08-10 | Biogal Gyogyszergyar Rt | Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
US6335023B1 (en) | 1999-06-30 | 2002-01-01 | Ruey J. Yu | Oligosaccharide aldonic acids and their topical use |
US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
IL137363A (en) | 2000-07-18 | 2005-12-18 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
IL150907A (en) | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
-
2000
- 2000-02-03 WO PCT/US2000/002880 patent/WO2000046389A1/en not_active Application Discontinuation
- 2000-02-03 CA CA002360865A patent/CA2360865A1/en not_active Abandoned
- 2000-02-03 HU HU0300363A patent/HUP0300363A2/hu unknown
- 2000-02-03 US US09/497,807 patent/US6509177B1/en not_active Expired - Fee Related
- 2000-02-03 YU YU55601A patent/YU55601A/sh unknown
- 2000-02-03 CZ CZ20012724A patent/CZ20012724A3/cs unknown
- 2000-02-03 CN CNB008058784A patent/CN1203184C/zh not_active Expired - Fee Related
- 2000-02-03 AU AU29808/00A patent/AU762768B2/en not_active Ceased
- 2000-02-03 KR KR1020017009825A patent/KR20010113674A/ko not_active Application Discontinuation
- 2000-02-03 PL PL00358615A patent/PL358615A1/xx not_active Application Discontinuation
- 2000-02-03 CN CNA2005100056737A patent/CN1670217A/zh active Pending
- 2000-02-03 JP JP2000597448A patent/JP2003515311A/ja not_active Ceased
- 2000-02-03 EP EP00908473A patent/EP1151131A4/en not_active Withdrawn
- 2000-02-03 IL IL14467900A patent/IL144679A0/xx active IP Right Grant
- 2000-02-03 SK SK1089-2001A patent/SK10892001A3/sk unknown
- 2000-02-03 BR BR0009179-0A patent/BR0009179A/pt not_active IP Right Cessation
- 2000-02-03 MX MXPA01007806A patent/MXPA01007806A/es not_active Application Discontinuation
- 2000-02-03 TR TR2001/02234T patent/TR200102234T2/tr unknown
-
2001
- 2001-07-31 IS IS6028A patent/IS6028A/is unknown
- 2001-07-31 HR HR20010576A patent/HRP20010576A2/hr not_active Application Discontinuation
- 2001-08-01 IL IL144679A patent/IL144679A/en not_active IP Right Cessation
- 2001-08-02 NO NO20013791A patent/NO20013791L/no not_active Application Discontinuation
- 2001-08-03 BG BG105776A patent/BG105776A/xx unknown
- 2001-10-11 US US09/975,796 patent/US6506591B2/en not_active Expired - Fee Related
-
2002
- 2002-05-02 HK HK02103290.9A patent/HK1041903A1/zh unknown
- 2002-11-12 US US10/293,675 patent/US7078223B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1151131A1 (en) | 2001-11-07 |
KR20010113674A (ko) | 2001-12-28 |
BR0009179A (pt) | 2001-11-27 |
MXPA01007806A (es) | 2003-06-04 |
PL358615A1 (en) | 2004-08-09 |
CN1203184C (zh) | 2005-05-25 |
IL144679A (en) | 2007-06-17 |
HK1041903A1 (zh) | 2002-07-26 |
AU762768B2 (en) | 2003-07-03 |
CN1670217A (zh) | 2005-09-21 |
IS6028A (is) | 2001-07-31 |
WO2000046389A9 (en) | 2001-09-07 |
AU2980800A (en) | 2000-08-25 |
JP2003515311A (ja) | 2003-05-07 |
IL144679A0 (en) | 2002-06-30 |
YU55601A (sh) | 2003-02-28 |
NO20013791L (no) | 2001-10-02 |
HRP20010576A2 (en) | 2002-08-31 |
US20030100083A1 (en) | 2003-05-29 |
SK10892001A3 (sk) | 2002-06-04 |
CN1354798A (zh) | 2002-06-19 |
HUP0300363A2 (hu) | 2004-06-28 |
CZ20012724A3 (cs) | 2001-12-12 |
US7078223B2 (en) | 2006-07-18 |
WO2000046389A1 (en) | 2000-08-10 |
CA2360865A1 (en) | 2000-08-10 |
US6509177B1 (en) | 2003-01-21 |
EP1151131A4 (en) | 2004-05-12 |
BG105776A (en) | 2002-05-31 |
US20020042103A1 (en) | 2002-04-11 |
US6506591B2 (en) | 2003-01-14 |
NO20013791D0 (no) | 2001-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Oskay et al. | Antibacterial activity of some actinomycetes isolated from farming soils of Turkey | |
TR200102234T2 (tr) | Psödomonik asit A antibiyotiğinin mikrobiyolojik yöntem ile hazırlanması için işlem | |
ATE173264T1 (de) | Antiparasitäre pyrrolobenzoxazin verbindungen | |
Hemashenpagam | Purification of secondary metabolites from soil actinomycetes | |
CY1106698T1 (el) | Νeος μικροοργανισμος | |
DE69917061D1 (de) | Nitrocumarine für den nachweis aller mikroorganismen | |
Rai et al. | Nickel induced stimulation of growth, heterocyst differentiation, 14CO2 uptake and nitrogenase activity in Nostoc muscorum | |
HUP0105286A2 (hu) | Eljárás pszeudomonsav A izolálására pszeudomonsav-komplex tartalmú fermentléből | |
DK1216237T3 (da) | Proces til fremstilling af mycophenolsyre og derivater deraf | |
AU6475600A (en) | Antibiotic caprazamycins and process for producing the same | |
ATE114710T1 (de) | Enzyme aus dem bacillus pabuli zum abbau der zellwand. | |
Sineva et al. | Acidotolerant actinomycetes of the genus Micromonospora are producers of antibiotic compounds | |
KR102085764B1 (ko) | 식물 생장 촉진 및 식물병 방제 활성을 갖는 슈도모나스 플레코글로시시다 ang14 균주 및 이의 용도 | |
El-Abyad et al. | Antimicrobial activities of Streptomyces pulcher, S. canescens and S. citreofluorescens against fungal and bacterial pathogens of tomato in vitro | |
Anusha et al. | A study on biodegradation of propoxur by bacteria isolated from municipal solid waste | |
Atta et al. | Microbiological studies on cultural, physiological characteristics and antimicrobial activities of Streptomyces cyaneus-AZ-13Zc | |
Sato et al. | Isolation from soil of aerobic chemoheterotrophic bacteria capable of decomposing methanethiol and hydrogen sulfide | |
Ningsih et al. | Antibacterial activity of Microbispora rosea subsp. rosea SL3-2-R-1 grown on different media and solidifying agents | |
WO1998037038A3 (de) | Methode der stickstoffbindung aus der luft, mobilisation der phosphorverbindungen und der zersetzung des ölsedimentes | |
PT73865B (en) | Process for preparing novel macrocyclic lactones | |
Vijayalakshmi et al. | Identification and characterization of Stenotrophomonas rhizophila isolated from rhizosphere soil of Tephrosia purpurea L.(Green manure crop) of Tamil Nadu | |
Najm et al. | Evaluation of Antimicrobial-producing Actinomycetes Isolated from Regions in Baghdad City. | |
KUMAR et al. | 2. DIVERSITY AND ANTIBACTERIAL POTENTIAL OF ENDOPHYTIC ACTINOMYCETES ISOLATED FROM MEDICINAL PLANTS OF RAJKOT, INDIA by RAVI RANJAN KUMAR1 AND VASANTBA J JADEJA2 | |
Subhashini et al. | Isolation of Streptomyces from tobacco soils that show antimicrobial activity | |
Obando Castellanos et al. | Analysis of the denitrification pathway and greenhouse gases emissions in Bradyrhizobium sp. strains used as biofertilizers in South America |